Docetaxel With or Without TAK-117 (MLN1117) in Participants With Locally Advanced or Metastatic Non-small Cell Lung Cancer

PHASE1/PHASE2TerminatedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

June 3, 2015

Primary Completion Date

January 12, 2017

Study Completion Date

January 20, 2017

Conditions

Non-small Cell Lung Cancer

Interventions

DRUG

Docetaxel

Docetaxel intravenous infusion

DRUG

TAK-117

TAK-117 Tablets

Trial Locations (11)

San Diego

Atlanta

Farmington Hills

Rochester

St Louis

Chattanooga

Edmonton

Toronto

Amsterdam

Hoofddorp

Maastricht